Printer Friendly

Uncommon Infections in Children Suggest Underlying Immunodeficiency: A Case of Infective Endocarditis in a 3-Year-Old Male.

1. Introduction

IE results from bacterial or fungal infection and is associated with significant morbidity and mortality. Risk factors of IE include congenital abnormality of the heart and prosthetic valves [1, 2]. In patients with native valves and normal cardiac structure, IE has been associated with cardiac surgery secondary to trauma and intravenous drug use [3]. Endocarditis is uncommon in individuals with healthy hearts, approximately 8-10% of cases of IE in pediatric patients occur in the absence of preexisting cardiac disease [4]. Limited literature exists on IE in previously healthy children, and the pathogenesis and underlying risk factors are largely unknown [5].

PAD is a broad category of immunodeficiencies that can result from defects in multiple components of the immune system, including B and/or T cell defects, inadequate or absent antibodies. Various disorders within this category have been identified, including X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), IgA deficiency, and autosomal recessive agammaglobulinemia (ARA). While each of these disorders carries its own unique genetic profile and clinical presentation, patients with PAD often present with recurrent and/or abnormally severe infections. Diagnosis is made based on immunoglobulin levels, flow cytometry and, ultimately, confirmatory genetic testing. PAD patients also have increased risk of both autoimmunity [6] and malignancy [7].

The age of presentation of PAD ranges but can begin to present as early as three months of age following loss of maternal antibody protection. Due to the frequency of infections in young children as their immune systems develop, many physicians may overlook frequent or abnormal infections as normal immature immunity of pediatrics or other benign causes, yet as many as 1 in 2000 children have a PAD [8]. However, delaying diagnosis of PAD is detrimental to health and development. In our case, a 3-year-old male was found to have IE despite having no known risk factors. Our patient illustrates that PAD should be considered in the differential diagnosis of a patient with no underlying risk factors who develops a serious uncommon infection such as endocarditis.

2. Case Report

A 3-year-old previously healthy male presented to the emergency department with a fever of unknown origin of approximately four weeks duration. As an outpatient, he had multiple evaluations in the last year and had been diagnosed with pharyngitis followed by otitis media and received full courses of amoxicillin and azithromycin. Despite antibiotics, he continued to have daily fevers up to 102.5 F. He also had complaints of weight loss (7 lbs), fatigue, nonproductive cough, and constipation. Vital signs at presentation included a fever of 101.7 F, heart rate of 135, and a respiratory rate of 20.

Physical exam revealed dry mucous membranes, posterior pharynx erythema without tonsillar exudates, posterior cervical lymphadenopathy, normal cardiovascular and respiratory exams, mild abdominal distention without organomegaly or significant tenderness, and delayed capillary refill of four seconds. Other exam findings were within normal limits.

Blood culture was positive for Enterococcus faecalis, prompting transthoracic echocardiogram which was positive for a 3 x 5 mm vegetation on the anterior mitral valve leaflet confirming endocarditis (Figure 1). The patient was started on intravenous ampicillin, which was terminated 14 days into therapy due to a suspected ampicillin-induced neutropenia (ANC 100 cells/[mm.sup.3]). He was then transitioned to vancomycin and gentamicin for a total antibiotic duration of four weeks.

After completion of his four-week course of antibiotics, the patient continued to develop recurrent fevers, and further infectious disease showed a PCR positive for Clostridium difficile, which was treated with metronidazole. Given his history of endocarditis with no identifiable risk factors, an immunological workup was perused. The workup was consistent with low IgG, IgA, and IgM levels (Table 1).

Following the immunology workup, the patients Bruton tyrosine kinase (Btk) gene was sequenced to evaluate XLA. The identified gene was c. 1178-3T > G, a variant of uncertain significance in the Btk gene, presumed to be the cause of his agammaglobulinemia. Further immune assessment of the B cell subsets as seen in Table 2 showed an absence of CD19+ B cells. The intracellular Btk protein expression was decreased in monocytes (MFI = 2.06) relative to experimental control (MFI = 7.99). This result appears to be suggestive of a diagnosis of XLA.

Since the diagnosis, he has been receiving regularly scheduled intravenous immunoglobulin (IVIG) infusions and remains symptom free for the last four months.

3. Discussion

IE is rare in the pediatric population and carries a high risk of morbidity and mortality. The incidence has been reported at a rate of 0.34 to 0.64 cases per 100,000 per year [5]. Majority of cases result from a structural defect or congenital heart disease [2]. Approximately 10% of cases have no underlying heart disease, and the cause is largely unknown [4]. Our case is of a 3-year-old who presented with endocarditis without any identifiable risk factors who was found to have PAD upon further workup. Since pediatric patients commonly have infections, PAD is commonly overlooked. In the cases of abnormal infections the cause must be identified, and PAD should be at the top of that differential.

Majority of patients with PAD are diagnosed when they develop a severe infection secondary to their lack of protective immunoglobin [9]. Infections which are commonly reported include recurrent pneumonia, empyema, sinusitis, recurrent otitis, sepsis, recurrent meningitis, or septic arthritis [10-12]. In those without protective B cells, bacterial infections typically begin three months after birth when maternal IgG is reduced below the protective level and most patients are diagnosed prior to the age of five [12]. Many of these infections are not severe and are also often seen in immunocompetent children. The occurrence of serious infections such as IE however is rare and an important clue to prompt further workup to identify any underlying PAD.

There are several types of PAD. One example is the XLA or Bruton's agammaglobulinemia which is a rare genetic disorder with a prevalence of 1 in every 19,000 male births in the United States [13]. B cell formation is attenuated due to a mutation in the Btk gene which alters the Btk protein involved in B cell differentiation [14, 15]. The Btk gene was identified in 1993, and since then numerous gene mutation sites have been identified [7]. Our patient has a variant Btk mutation that has not been previously reported in literature. The clinical picture of our patient is consistent with a lack of B cell differentiation causing a lack of immunoglobulin and subsequently allowing recurring and serious infections; therefore, it is plausible that the mutation can be causative. It is important to note however that this variant gene mutation is of unknown significance and further investigation into its relevance for agammaglobulinemia is ongoing.

In conclusion, endocarditis is a serious infection which is uncommon in the healthy pediatric population with no known risk factors. PAD is often overlooked as immunocompetent children often present with common infections such as otitis media and pneumonia. Our case emphasizes that pediatric patients presenting with more serious and uncommon infections such as endocarditis should be carefully evaluated for underlying cause. Our case emphasizes that PAD should be at the top of the differential in such patients as delay in diagnosis and treatment can lead to increased morbidity and mortality.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


[1] T. L. Kiefer and T. M. Bashore, "Infective endocarditis: a comprehensive overview," Reviews in Cardiovascular Medicine, vol. 13, no. 2-3, pp. e105-e120, 2012.

[2] J. A. Johnson, T. G. Boyce, F. Cetta, J. M. Steckelberg, and J. N. Johnson, "Infective endocarditis in the pediatric patient: a 60-year single-institution review," Mayo Clinic Proceedings, vol. 87, no. 7, pp. 629-635, 2012.

[3] J. A. Stockheim, E. G. Chadwick, S. Kessler et al., "Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children?," Clinical Infectious Diseases, vol. 27, no. 6, pp. 1451-1456, 1998.

[4] Y.-T. Lin, K.-S. Hsieh, Y.-S. Chen, I.-F. Huang, and M.-F. Cheng, "Infective endocarditis in children without underlying heart disease," Journal of Microbiology, Immunology and Infection, vol. 46, no. 2, pp. 121-128, 2013.

[5] M. Saifi and C. A. Wysocki, "Autoimmune disease in primary immunodeficiency," Immunology and Allergy Clinics of North America, vol. 35, no. 4, pp. 731-752, 2015.

[6] R. S. Shapiro, "Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists," American Journal of Hematology, vol. 86, no. 1, pp. 48-55, 2011.

[7] C. E. Reust, "Evaluation of primary immunodeficiency disease in children," American Family Physician, vol. 87, no. 11, pp. 773-778, 2013.

[8] N. Rezaei, M. Hedayat, A. Aghamohammadi, and K. E. Nichols, "Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies," Journal of Allergy and Clinical Immunology, vol. 127, no. 6, pp. 1329-1341, 2011.

[9] J. Chun, T. J. Lee, J. W. Song, J. A. Linton, and D. S. Kim, "Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital," Yonsei Medical Journal, vol. 49, no. 1, pp. 28-36, 2008.

[10] G. Kanra, S. Arslan, M. Ergin et al., "Recurrent purulent meningitis in a patient with Bruton's disease," Turkish Journal of Pediatrics, vol. 29, no. 2, pp. 107-110, 1987.

[11] L. Saiman, A. Prince, and W. M. Gersony, "Pediatric infective endocarditis in the modern era," Journal of Pediatrics, vol. 122, no. 6, pp. 847-853, 1993.

[12] K. H. Lee, S. D. Shyur, S. H. Chu et al., "Clinical manifestations and BTK gene defect in 4 unrelated Taiwanese families with Bruton's disease," Asian Pacific Journal of Allergy and Immunology, vol. 29, no. 3, pp. 260-265, 2011.

[13] IDF SCID, Newborn Screening Campaign, Immune Deficiency Foundation, October 2017 https://primaryimmune. org/idf-advocacy-center/idf-scid-newborn-screening-campaign.

[14] Y. Wang, H. Kanegane, O. Sanal et al., "Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia," Human Mutation, vol. 18, p. 356, 2001.

[15] H. D. Ochs and C. I. Smith, "X-linked agammaglobulinemia. A clinical and molecular analysis," Medicine, vol. 75, no. 6, pp. 287-299, 1996.

Aisha Shakoor (iD), (1) Ahmed El-Isa (iD), (2) Elizabeth Kinsella, (3) Ryan Halas, (4) and Andrey Leonov (5)

(1) Department of Family Medicine, Western Michigan University, Kalamazoo, MI, USA

(2) Department of Pediatrics, Western Michigan University, Kalamazoo, MI, USA

(3) Western Michigan University Homer Stryker School of Medicine, Kalamazoo, MI, USA

(4) Department of Internal and Pediatric Medicine, Western Michigan University, Kalamazoo, MI, USA

(5) Department of Pediatric and Adolescent Medicine, Western Michigan University, Kalamazoo, MI, USA

Correspondence should be addressed to Aisha Shakoor;

Received 31 October 2017; Revised 5 March 2018; Accepted 11 March 2018; Published 1 April 2018

Academic Editor: Tomoyuki Shibata

Caption: Figure 1: Small 3 x 5 mm vegetation on atrial aspect of the mitral valve as visualized on echocardiogram Apical four chamber view with apex up and posterior angulation.
Table 1: Immune workup showed the following labs.

Immunoglobin    Level   Reference range

IgG              <30     331-1090 mg/dL
IgA              <5       13-157 mg/dL
IgM               6       41-190 mg/dL

Table 2: Immune assessment B cell subsets.

Lymphocyte subsets       Level        Reference range

% CD19 (B cells)          0%              13-39%
CD19 (B cells)        0 cells/mcL   370-2306 cells/mcL
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Case Report
Author:Shakoor, Aisha; Isa, Ahmed El-; Kinsella, Elizabeth; Halas, Ryan; Leonov, Andrey
Publication:Case Reports in Infectious Diseases
Date:Jan 1, 2018
Previous Article:A Case of Pacemaker Endocarditis Caused by Aerococcus urinae.
Next Article:Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters